A randomised double-blind intervention study which was performed among 90 patients with ACS, revealed early and highly significant reductions in plasma concentrations of CRP levels by using 40 mg/dL of atorvastatin given for a month and also an early significant reduction in T-C and LDL-C.
← all excerpts
Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndrome.
1
—
—